` 8473 (SBI Holdings Inc) vs Nikkei 225 Comparison - Alpha Spread

8473
vs
Nikkei 225

Over the past 12 months, has outperformed Nikkei 225, delivering a return of -4% compared to the Nikkei 225's 6% drop.

Stocks Performance
8473 vs Nikkei 225

Loading

Performance Gap
8473 vs Nikkei 225

Loading
8473
Nikkei 225
Difference

Performance By Year
8473 vs Nikkei 225

Loading
8473
Nikkei 225
Add Stock

Competitors Performance
SBI Holdings Inc vs Peers

Nikkei 225
8473
MS
GS
EFGD
SCHW
Add Stock

SBI Holdings Inc
Glance View

Market Cap
1.1T JPY
Industry
Financial Services

SBI Holdings Inc., originally a financial services arm of the SoftBank Group, has transformed itself into a formidable independent entity, pioneering the digital finance landscape in Japan and beyond. Established in 1999, the company embarked on a mission to revolutionize traditional banking and investment services by embracing the burgeoning opportunities presented by the internet and technology. At its core, SBI Holdings leverages its diverse fintech ecosystem, spanning asset management, banking, and securities, to seamlessly integrate these services into a cohesive model. Its approach is underpinned by strategic partnerships and investments across global ventures, manifesting in a robust portfolio that includes ventures in AI, blockchain, and cryptocurrency. By doing so, the company skillfully navigates the intersection of finance and innovation, continually setting benchmarks for the industry. What truly distinguishes SBI Holdings is its dynamic revenue generation model, rooted in diversification. It achieves this by maintaining a flexible yet comprehensive approach to its three principal business segments: Financial Services, Asset Management, and Biotechnology-Related Business. Through its financial services division, SBI Holdings earns substantial income from traditional banking services, brokerages, and insurance, efficiently utilizing digital platforms to reach a broad customer base. The Asset Management arm thrives by managing investment funds, private equity, and the intricate world of venture capital, capitalizing on emerging tech companies. Interestingly, its Biotechnology segment is a strategic exploration into the promising future of life sciences, highlighting its intention to capitalize on health innovations. This blended business model allows SBI to harness varied revenue streams while creating synergy between technology and finance, propelling it toward sustainable growth and innovation-driven success.

Intrinsic Value
12 142.12 JPY
Undervaluation 70%
Intrinsic Value
Price
Back to Top